Back to 
BlackRock, Inc.
BlackRock, Inc.
CRNX7 quarters
Position history for BlackRock, Inc.'s holdings in CRINETICS PHARMACEUTICALS IN
BlackRock, Inc. holds 9.8M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $365.2M as of 2026-Q2. The position was increased (+15.1% shares). CRNX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$365.2M
Current Shares
9.8M
Total Value Change
-$19.1M
Total Shares Change
+2.2M
Quarter-by-Quarter History
Other major holders of CRNX: FMR LLC